HomeAbout SPIFor PatientsFor PhysiciansSPI DoctorsDirections206.215.2480

Clinical Training CoursesTechnical AssistanceBrachytherapy ConferencePCa Commentary



PCa Commentary

LYCOPENE - Small study finds lycopene suppresses HG-PIN’s transition into prostate cancer.

(April 2006)

There is strong support for a benefit of lycopene in retarding prostate cancer at all clinical stages ( see Feb/Mar PCa Commentary - “Diet and Prostate Cancer” ). Now evidence from a small study indicates that lycopene can interrupt the progression of HG-PIN into occult prostate cancer: “Lycopene as a chemopreventative agent in the treatment of high-grade prostate intraepithelial neoplasm, Mohanty NK, Urologic Oncology 23 (2005) 383-385.

The study design: Prostate cancer was excluded by careful work-up and prostate biopsy in 230 men who then underwent a TURP for their BPH. Of this group 40 were found to have HG-PIN. Twenty were treated with 4 mg lycopene (Lyc-O-Mato) twice daily for one year and instructed to follow their regular diet. The untreated control group was advised to reduce the intake of tomato products and melon.

At one year follow-up the median PSA in the treatment group had fallen from 6.07 to 3.5 ng/mL, but PSA in the control group increased from 6.55 to 8.06 ng/mL. Unique to this study, baseline and 1 year serum lycopene levels were measured (normal - 300 ng/mL): mean values for the treated group - 360 ng/mL increasing to 680 ng/mL at one year; and in the control group, 378 ng/mL at baseline dropping to 180 ng/mL.

PSA and lycopene levels, and DREs were checked at 3 month intervals during the 2 year study. Over the second year of the study, any man who developed an abnormal DRE or an increased PSA underwent prostate biopsy. Result: adenocarcinoma was diagnosed in 2 men in the treated group versus 6 in the control group.

The authors find the data very suggestive, but acknowledge that such a small study needs confirmation. However, the study was well done, and was especially notable for the inclusion of serum lycopene measurements.

 The lycopene “dose” most cited in the literature is 30 mg/day, which can easily be obtained from 8 oz. tomato juice daily and one or two servings of tomato based products weekly.

In clinical practice when HG-PIN has been diagnosed and follow-up advised, there is no downside to recommending a high lycopene diet, which has no toxicity and is well tolerated.

Bottom Line: Evidence suggests lycopene as a beneficial chemopreventive agent for men with HG-PIN

« Back to Article List


(c) 2006 Seattle Prostate Institute -  All rights reserved.